Sign in

CIK 0001501697 · Non-accelerated filer<br>Smaller reporting company

X4 Pharmaceuticals, Inc

Sign in to watch
Ticker
XFOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
273181608
Phone
857-529-8300
Business address
61 NORTH BEACON STREET, 4TH FLOOR, BOSTON, MA, 02134
Former names
Arsanis, Inc.
  1. 4 Insider Changes in Ownership
  2. 4 Insider Changes in Ownership
  3. 8-K Event Exit or restructuring costs · Regulation FD disclosure
  4. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  5. 4 Insider Changes in Ownership
  6. 4 Insider Changes in Ownership
  7. 4 Insider Changes in Ownership
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. S-8 Other Securities Offered to Employees in Benefit Plans
  17. 8-K Event Material agreement · Regulation FD disclosure
  18. UPLOAD Other SEC-generated Letter
  19. CORRESP Other Correspondence Between Filers and SEC Staff
  20. UPLOAD Other SEC-generated Letter

Page 7 of 41 · 818 filings